These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8557389)

  • 1. Synergy of simultaneous administration of ofloxacin and granulocyte colony-stimulating factor in killing of Escherichia coli by human neutrophils.
    Kropec A; Lemmen SW; Grundmann HJ; Engels I; Daschner FD
    Infection; 1995; 23(5):298-300. PubMed ID: 8557389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of human neutrophils, ceftazidime and granulocyte colony-stimulating factor on killing of Escherichia coli.
    Daschner FD; Grundmann H; Anding K; Lemmen S
    Eur J Clin Microbiol Infect Dis; 1995 Jun; 14(6):536-9. PubMed ID: 7588830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of in vitro bactericidal activity of neutrophils from trauma patients in the presence of granulocyte colony-stimulating factor.
    Anding K; Kropec A; Schmidt-Eisenlohr E; Benzing A; Geiger K; Daschner F
    Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):121-4. PubMed ID: 7684679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective polymorphonuclear leukocyte functions in children receiving chemotherapy for cancer are partially restored by recombinant human granulocyte colony-stimulating factor in vitro.
    Lejeune M; Sariban E; Cantinieaux B; Ferster A; Devalck C; Fondu P
    J Infect Dis; 1996 Oct; 174(4):800-5. PubMed ID: 8843219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens.
    Liles WC; Huang JE; van Burik JA; Bowden RA; Dale DC
    J Infect Dis; 1997 Apr; 175(4):1012-5. PubMed ID: 9086172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils.
    Roilides E; Walsh TJ; Pizzo PA; Rubin M
    J Infect Dis; 1991 Mar; 163(3):579-83. PubMed ID: 1704903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
    Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
    J Infect Dis; 1999 Apr; 179(4):1038-41. PubMed ID: 10068606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo.
    Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
    J Infect Dis; 1999 May; 179(5):1301-4. PubMed ID: 10191242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils released from the bone marrow by granulocyte colony-stimulating factor sequester in lung microvessels but are slow to migrate.
    van Eeden SF; Lawrence E; Sato Y; Kitagawa Y; Hogg JC
    Eur Respir J; 2000 Jun; 15(6):1079-86. PubMed ID: 10885427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of in vitro and in vivo cytokine treatment, leucapheresis and irradiation on the function of human neutrophils: implications for white blood cell transfusion therapy.
    Cohen DM; Bhalla SC; Anaissie EJ; Hester JP; Savary CA; Rex JH
    Clin Lab Haematol; 1997 Mar; 19(1):39-47. PubMed ID: 9146946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
    Chiller T; Farrokhshad K; Brummer E; Stevens DA
    Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of granulocyte colony-stimulating factor and interferon-gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species.
    Roilides E; Holmes A; Blake C; Pizzo PA; Walsh TJ
    J Leukoc Biol; 1995 Apr; 57(4):651-6. PubMed ID: 7536791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity response of blood neutrophils from critically ill patients to in vitro granulocyte colony-stimulating factor stimulation.
    Yang K; Azoulay E; Attalah L; Zahar JR; Van de Louw A; Cerf C; Soussy CJ; Duvaldestin P; Brochard L; Brun-Buisson C; Harf A; Delclaux C
    Intensive Care Med; 2003 Mar; 29(3):396-402. PubMed ID: 12541157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing of alpha-haemolytic and non-haemolytic Escherichia coli strains in human serum and polymorphonuclear leucocytes.
    Siegfried L; Puzová H; Kmetová M; Kerestesová A
    J Med Microbiol; 1992 Jul; 37(1):3-7. PubMed ID: 1625312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against staphylococci.
    Pascual A; Martínez-Martínez L; Perea EJ
    Chemotherapy; 1989; 35(1):17-22. PubMed ID: 2721289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro.
    Hellmich B; Csernok E; Trabandt A; Gross WL; Ernst M
    Clin Exp Immunol; 2000 May; 120(2):392-8. PubMed ID: 10792393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective phagocytosis and killing of Candida albicans via targeting FcgammaRI (CD64) or FcalphaRI (CD89) on neutrophils.
    van Spriel AB; van den Herik-Oudijk IE; van Sorge NM; Vilé HA; van Strijp JA; van de Winkel JG
    J Infect Dis; 1999 Mar; 179(3):661-9. PubMed ID: 9952373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.